Managing challenging patients with Waldenström’s macroglobulinemia
Waldenström’s macroglobulinemia: Treatment methods and clonal evolution
Navigating advances in the myeloma landscape over the past couple of years
What is the rationale for novel combination therapies?
Niels van de Donk
Why daratumumab is effective in multiple myeloma - results from the CASTOR trial